RT Journal Article
SR Electronic
T1 A new model of unreported COVID-19 cases outperforms three known epidemic-growth models in describing data from Cuba and Spain
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.29.21259707
DO 10.1101/2021.06.29.21259707
A1 Ramirez-Torres, Erick E.
A1 Selva Castañeda, Antonio R.
A1 Randez, Luis
A1 Valdés García, Luis E.
A1 Cabrales, Luis E. Bergues
A1 Sisson, Scott A.
A1 Montijano, Juan I.
YR 2021
UL http://medrxiv.org/content/early/2021/07/21/2021.06.29.21259707.abstract
AB Estimating the unreported cases of Covid-19 in a region/country is a complicated problem. We propose a new mathematical model that, combined with a deterministic model of the total growth of cases, describes the time evolution of the unreported cases for each reported Covid-19 case. The new model considers the growth of unreported cases in plateau periods and the decrease towards the end of an epidemic wave. We combined the new model with a Gompertz-growth model, a generalized logistic model, and a susceptible-infectious-removed (SIR) model; and fitted them via Bayesian methods to data from Cuba and Spain. The combined-model fits yielded better Bayesian-Information-Criterion values than the Gompertz, logistic, and SIR models alone. This suggests the new model can achieve improved descriptions of the evolution of a Covid-19 epidemic wave. The new model is also able to provide reliable predictions of the epidemic evolution in a short period of time. We include in the paper the steps that researchers should take to use the new model for predictions with other data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No personal data of any individual was used in the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are available. https://covid19cubadata.github.io https://cnecovid.isciii.es/covid19